Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study

Journal of the Neurological Sciences

Volumn 246, Issue 1-2, 2006, Pages 31-35

  Mazzeo, Anna ^a   Toscano, Antonio ^a   Stromillo, Maria L ^b   Battaglini, Marco ^b   Messina, Corrado ^a   Federico, Antonio ^b   Vita, Giuseppe ^a   De Stefano, Nicola ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

Axonal damage; Brain; Familial amyloid polyneuropathy; Magnetic resonance spectroscopy

Indexed keywords

BRAIN ENZYME; CREATINE; PREALBUMIN;

ADULT; AGED; AMYLOID NEUROPATHY; AMYLOIDOSIS; ARTICLE; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NERVE FIBER; PHENOTYPE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

ADULT; AMYLOID NEUROPATHIES, FAMILIAL; ASPARTIC ACID; AXONS; BRAIN CHEMISTRY; CREATINE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREALBUMIN;

EID: 33744505181     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.01.017     Document Type: Article

References (28)

1. Adams D. Hereditary and acquired amyloid neuropathies. J Neurol 248 (2001) 647-657
2. Arpa Gutierrez J., Morales C., Lara M., Munoz C., Garcia-Rojo M., Caminero A., et al. Type I familial amyloid polyneuropathy and pontine haemorrhage. Acta Neuropathol (Berl) 86 (1993) 542-545
3. Herrick M.K., DeBruyne K., Horoupian D.S., Skare J., Vanefsky M.A., and Ong T. Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene. Neurology 47 (1996) 988-992
4. Klein C.J., Nakumura M., Jacobson D.R., Lacy M.Q., Benson M.D., and Petersen R.C. Transthyretin amyloidosis (serine 44) with headache, hearing loss, and peripheral neuropathy. Neurology 51 (1998) 1462-1464
5. Vidal R., Garzuly F., Budka H., Lalowski M., Linke R.P., Brittig F., et al. Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G). Am J Pathol 148 (1996) 361-366
6. Petersen R.B., Goren H., Cohen M., Richardson S.L., Tresser N., Lynn A., et al. Transthyretin amyloidosis: a new mutation associated with dementia. Ann Neurol 41 (1997) 307-313
7. Brett M., Persey M.R., Reilly M.M., Revesz T., Booth D.R., Booth S.E., et al. Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. Brain 122 (1999) 183-190
8. Mascalchi M., Salvi F., Pirini M.G., D'Errico A., Ferlini A., Lolli F., et al. Transthyretin amyloidosis and superficial siderosis of the CNS. Neurology 53 (1999) 1498-1503
9. Jin K., Sato S., Takahashi T., Nakazaki H., Date Y., Nakazato M., et al. Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing repeated subarachnoid haemorrhages with superficial siderosis. J Neurol Neurosurg Psychiatry 75 (2004) 1463-1466
10. Sousa M.M., and Saraiva M.J. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling. Prog Neurobiol 71 (2003) 385-400
11. Garzuly F., Vidal R., Wisniewski T., Brittig F., and Budka H. Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly). Neurology 47 (1996) 1562-1567
12. Ushiyama M., Ikeda S., and Yanagisawa N. Transthyretin-type cerebral amyloid angiopathy in type I familial amyloid polyneuropathy. Acta Neuropathol (Berl) 81 (1991) 524-528
13. Rudkin T.M., and Arnold D.L. Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders [In Process Citation]. Arch Neurol 56 (1999) 919-926
14. De Stefano N., Narayanan S., Francis G.S., Arnaoutelis R., Tartaglia M.C., Antel J.P., et al. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 58 (2001) 65-70
15. Simmons M.L., Frondoza C.G., and Coyle J.T. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45 (1991) 37-45
16. Bjartmar C., Battistuta J., Terada N., Dupree E., and Trapp B.D. N-Acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve. Ann Neurol 51 (2002) 51-58
17. De Stefano N., Matthews P.M., Antel J.P., Preul M., Francis G., and Arnold D.L. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol 38 (1995) 901-909
18. Austin S.J., Connelly A., Gadian D.G., Benton J.S., and Brett E.M. Localized 1H NMR spectroscopy in Canavan's disease: a report of two cases. Magn Reson Med 19 (1991) 439-445
19. Martin E., Capone A., Schneider J., Hennig J., and Thiel T. Absence of N-acetylaspartate in the human brain: impact on neurospectroscopy?. Ann Neurol 49 (2001) 518-521
20. Matthews P.M., De Stefano N., Narayanan S., Francis G.S., Wolinsky J.S., Antel J.P., et al. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol 18 (1998) 327-336
21. De Stefano N., Narayanan S., Matthews P.M., Mortilla M., Dotti M.T., Federico A., et al. Proton MR spectroscopy to assess axonal damage in multiple sclerosis and other white matter disorders. J Neurovirol 6 Suppl 2 (2000) 121-129
22. Hsu Y.Y., Du A.T., Schuff N., and Weiner M.W. Magnetic resonance imaging and magnetic resonance spectroscopy in dementias. J Geriatr Psychiatry Neurol 14 (2001) 145-166
23. Schuff N., Capizzano A.A., Du A.T., Amend D.L., O'Neill J., Norman D., et al. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology 58 (2002) 928-935
24. Rule R.R., Suhy J., Schuff N., Gelinas D.F., Miller R.G., and Weiner M.W. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Amyotroph Lateral Scler Other Motor Neuron Disord 5 (2004) 141-149
25. Goren H., Steinberg M.C., and Farboody G.H. Familial oculoleptomeningeal amyloidosis. Brain 103 (1980) 473-495
26. Mitsuhashi S., Yazaki M., Tokuda T., Yamamoto K., and Ikeda S. MRI analysis on a patient with the V30M mutation is characteristic of leptomeningeal amyloid. Amyloid 11 (2004) 265-267
27. Mazzeo A., Aguennouz M., Messina C., and Vita G. Immunolocalization and activation of transcription factor nuclear factor kappa B in dysimmune neuropathies and familial amyloidotic polyneuropathy. Arch Neurol 61 (2004) 1097-1102
28. Ghiso J., Wisniewski T., and Frangione B. Unifying features of systemic and cerebral amyloidosis. Mol Neurobiol 8 (1994) 49-64